MedTrace Logo

The Nolix Feasibility Efficacy and Safety Study

NCT04143867 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2021-08-16

No results posted yet for this study

Summary

This study is an open label, prospective, feasibility study with the Nolix device used for temporary treatment of Stress Urinary Incontinence (SUI) in subjects, serving as their own controls.

Conditions

  • Stress Urinary Incontinence

Interventions

DEVICE

Nolix Device

For temporary management of SUI

Sponsors & Collaborators

  • Gynamics LTD

    lead INDUSTRY

Principal Investigators

  • Boris Fridman, Dr. · Carmel Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04143867 on ClinicalTrials.gov